{
    "2018-07-05": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Key Developments from Ligand’s Partners Bode Well for It",
                "features": {
                    "keywords": [
                        "Ligand",
                        "partners",
                        "bode well"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-25",
                "original_text": "How Novartis’s Segments Did in Q1 2018",
                "features": {
                    "keywords": [
                        "Novartis",
                        "segments",
                        "Q1 2018"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-15",
                "original_text": "3 Best Biotech Acquisitions of 2018 (So Far)",
                "features": {
                    "keywords": [
                        "biotech",
                        "acquisitions",
                        "2018"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-05-10",
                "original_text": "Novartis’s Quarterly Revenue Trends and Estimates",
                "features": {
                    "keywords": [
                        "Novartis",
                        "revenue trends",
                        "estimates"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-30",
                "original_text": "How Novartis’s Valuation Compares",
                "features": {
                    "keywords": [
                        "Novartis",
                        "valuation",
                        "compares"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-06-20",
                "original_text": "The Swiss Stock Market Held On To A Small Gain After Late Sell-Off",
                "features": {
                    "keywords": [
                        "Swiss stock market",
                        "small gain",
                        "sell-off"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}